I had looked at them and thought it was too risky and Fibromyalgia seemed to be one of those indications that could result in a high placebo effect. If memory serves wasn't this the 2nd trial and the first one failed to reach significance? In fact if I recall correctly Cypress started the second trial before the results of the first were known much to Forrests disapproval. I wonder if this is enough for approval?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.